Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

Veri kaynağı ayrımı

• YÖKSİSYÖKSİS makale kaydı
• YÖKSİS dergi adıCurrent Problems in Cancer
• Katalog eşleşmesi (ISSN)Current Problems in Cancer
• Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)